ACM
FLNA

ACT Capital Management’s Filana Therapeutics FLNA Stock Holding History

ACT Capital Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$142K Buy
+3,400
New +$91.8K 0.2% 44
2021
Q3 		– Sell
-45,000
Closed -$3.85M – 130
2021
Q2 		$3.85M Buy
+45,000
New +$2.41M 1.98% 8

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACT Capital Management's FLNA Position: Q3 2022 in Review

ACT Capital Management opened a new position in Filana Therapeutics (FLNA) in Q3 2022: 3,400 shares worth $142K. The stake represents 0.2% of the portfolio and ranks #44 among its holdings. This is a return to the name: ACT Capital Management previously reported a position in FLNA as recently as Q2 2021.

ACT Capital Management first reported a position in FLNA in Q2 2021 and has held it in 2 quarters since. The position peaked at $3.85M in Q2 2021. 175 funds tracked by Wall St. Rank hold FLNA as of Q3 2022.

  • ACT Capital Management held 3,400 shares of Filana Therapeutics worth $142K as of Q3 2022.
  • Filana Therapeutics was a new ACT Capital Management position in Q3 2022.
  • Filana Therapeutics made up 0.2% of ACT Capital Management's portfolio in Q3 2022, its #44 holding.
  • ACT Capital Management first reported a position in Filana Therapeutics in Q2 2021 and has held it in 2 quarters since.
  • ACT Capital Management's Filana Therapeutics position peaked at $3.85M in Q2 2021.
  • 175 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2022.

Based on ACT Capital Management's 13F filing for Q3 2022, filed 3 Nov 2022.